Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed in the record history; these are minor version history updates on the page and do not affect study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedBanner notifying about lapse in government funding and operating status was removed; the trial history content and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check34 days agoChange DetectedThe new screenshot shows updated header/banner styling and minor layout tweaks to the version history list, while the core information (version dates and changes) remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange Detected- Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference12%

- Check70 days agoChange Detected- Updated the page version from v3.0.2 to v3.1.0. Minor overall impact, mainly reflects a version increment.SummaryDifference0.3%

- Check84 days agoChange DetectedUpdated Revision: v3.0.2 (replacing v3.0.1); removed the 'Back to Top' element.SummaryDifference0.7%

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.